Neuronetics, Inc. Common Stock
Symbol: STIM (NASDAQ)
Company Description:
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
- Today's Open: $3.47
- Today's High: $3.49
- Today's Low: $3.47
- Today's Volume: 2.45K
- Yesterday Close: $3.45
- Yesterday High: $3.71
- Yesterday Low: $3.4
- Yesterday Volume: 1.26M
- Last Min Volume: 30
- Last Min High: $3.49
- Last Min Low: $3.49
- Last Min VWAP: $3.49
- Name: Neuronetics, Inc. Common Stock
- Website: https://www.neurostar.com
- Listed Date: 2018-06-28
- Location: MALVERN, PA
- Market Status: Active
- CIK Number: 0001227636
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $228.13M
- Round Lot: 100
- Outstanding Shares: 66.12M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-08-12 | 4 | View |
2025-08-12 | SCHEDULE 13D/A | View |
2025-08-08 | 144 | View |
2025-08-08 | 144 | View |
2025-08-08 | 144 | View |
2025-08-07 | 144 | View |
2025-08-06 | 424B5 | View |
2025-08-05 | 10-Q | View |
2025-08-05 | 8-K | View |
2025-07-18 | EFFECT | View |
2025-07-16 | CORRESP | View |
2025-07-15 | 3 | View |
2025-07-15 | 4 | View |
2025-07-15 | 8-K | View |
2025-07-09 | UPLOAD | View |
2025-07-03 | S-3 | View |
2025-06-02 | SD | View |
2025-05-28 | 8-K | View |
2025-05-27 | 4 | View |
2025-05-27 | 4 | View |